Abstract
Primary amebic meningoencephalitis (PAM) is a fulminant central nervous system infection caused by the thermophilic free-living ameba Naegleria fowleri. Few survivals have been documented and adequate treatment is lacking. We report 2 PAM cases, 1 fatal and 1 surviving, treated with the novel antiparasitic agent miltefosine.
Author supplied keywords
Cite
CITATION STYLE
APA
Cope, J. R., Conrad, D. A., Cohen, N., Cotilla, M., Dasilva, A., Jackson, J., & Visvesvara, G. S. (2015). Use of the Novel Therapeutic Agent Miltefosine for the Treatment of Primary Amebic Meningoencephalitis: Report of 1 Fatal and 1 Surviving Case. Clinical Infectious Diseases, 62(6), 774–776. https://doi.org/10.1093/cid/civ1021
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free